|
2025-02-27 |
2025-02-25 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
12,529
-2.8%
8.53
USD 106,872
|
12,529
-2.8%
|
8.53
|
USD 106,872
|
|
|
2025-02-27 |
2025-02-25 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
4,895
-2.7%
8.53
USD 41,754
|
4,895
-2.7%
|
8.53
|
USD 41,754
|
|
|
2025-02-27 |
2025-02-25 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
3,756
-2.7%
8.53
USD 32,039
|
3,756
-2.7%
|
8.53
|
USD 32,039
|
|
|
2025-02-27 |
2025-02-25 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
3,756
-2.6%
8.53
USD 32,039
|
3,756
-2.6%
|
8.53
|
USD 32,039
|
|
|
2025-01-07 |
2025-01-06 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
4,000
-4.0%
12.51
USD 50,040
|
4,000
-4.0%
|
12.51
|
USD 50,040
|
|
|
2024-12-27 |
2024-12-24 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
8,400
-3.1%
11.87
USD 99,708
|
8,400
-3.1%
|
11.87
|
USD 99,708
|
|
|
2024-12-20 |
2024-12-18 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
3,482
-3.7%
11.41
USD 39,730
|
3,482
-3.7%
|
11.41
|
USD 39,730
|
|
|
2024-12-20 |
2024-12-18 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
4,632
-3.9%
11.41
USD 52,851
|
4,632
-3.9%
|
11.41
|
USD 52,851
|
|
|
2024-12-20 |
2024-12-18 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
4,693
-4.5%
11.41
USD 53,547
|
4,693
-4.5%
|
11.41
|
USD 53,547
|
|
|
2024-12-16 |
2024-12-12 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
3,489
-3.2%
12.52
USD 43,682
|
3,489
-3.2%
|
12.52
|
USD 43,682
|
|
|
2024-11-07 |
2024-11-05 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
8,000
-6.9%
15.64
USD 125,120
|
8,000
-6.9%
|
15.64
|
USD 125,120
|
|
|
2024-09-09 |
2024-09-05 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
8,000
-6.5%
18.09
USD 144,720
|
8,000
-6.5%
|
18.09
|
USD 144,720
|
|
|
2024-07-09 |
2024-07-05 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
8,000
-6.1%
16.33
USD 130,640
|
8,000
-6.1%
|
16.33
|
USD 130,640
|
|
|
2024-05-08 |
2024-05-07 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
5,606
-4.1%
30.06
USD 168,516
|
5,606
-4.1%
|
30.06
|
USD 168,516
|
|
|
2024-05-08 |
2024-05-06 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
20,277
-13.5%
28.54
USD 578,706
|
20,277
-13.5%
|
28.54
|
USD 578,706
|
|
|
2024-05-08 |
2024-05-06 |
PS
Planned sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
37,723
-20.1%
27.82
USD 1,049,454
|
37,723
-20.1%
|
27.82
|
USD 1,049,454
|
|
|
2024-02-02 |
2024-02-01 |
PS
Planned sale
|
Savill Corrine
Chief Business Officer
Officer
|
40,000
-19.4%
16.18
USD 647,200
|
40,000
-19.4%
|
16.18
|
USD 647,200
|
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
Savill Corrine
Chief Business Officer
Officer
|
40,000
-19.4%
14.09
USD 563,600
|
40,000
-19.4%
|
14.09
|
USD 563,600
|
|
|
2024-01-24 |
2024-01-23 |
PS
Planned sale
|
Savill Corrine
Chief Business Officer
Officer
|
21,316
-11.4%
12.46
USD 265,597
|
21,316
-11.4%
|
12.46
|
USD 265,597
|
|
|
2024-01-24 |
2024-01-22 |
PS
Planned sale
|
Savill Corrine
Chief Business Officer
Officer
|
4,125
-2.4%
12.02
USD 49,583
|
4,125
-2.4%
|
12.02
|
USD 49,583
|
|
|
2024-01-24 |
2024-01-22 |
PS
Planned sale
|
Savill Corrine
Chief Business Officer
Officer
|
14,559
-7.9%
12.18
USD 177,329
|
14,559
-7.9%
|
12.18
|
USD 177,329
|
|
|
2023-12-27 |
2023-12-26 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
4,272
-3.7%
9.24
USD 39,473
|
4,272
-3.7%
|
9.24
|
USD 39,473
|
|
|
2023-12-22 |
2023-12-21 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
1,860
-3.2%
8.50
USD 15,810
|
1,860
-3.2%
|
8.50
|
USD 15,810
|
|
|
2023-12-22 |
2023-12-21 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
1,920
-2.2%
8.50
USD 16,320
|
1,920
-2.2%
|
8.50
|
USD 16,320
|
|
|
2023-12-22 |
2023-12-21 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
1,145
-1.3%
8.50
USD 9,733
|
1,145
-1.3%
|
8.50
|
USD 9,733
|
|
|
2023-12-22 |
2023-12-21 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
1,400
-3.1%
8.50
USD 11,900
|
1,400
-3.1%
|
8.50
|
USD 11,900
|
|
|
2023-12-20 |
2023-12-18 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
238
-0.3%
8.22
USD 1,956
|
238
-0.3%
|
8.22
|
USD 1,956
|
|
|
2023-12-20 |
2023-12-18 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
386
-0.7%
8.22
USD 3,173
|
386
-0.7%
|
8.22
|
USD 3,173
|
|
|
2023-12-20 |
2023-12-18 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
398
-0.5%
8.22
USD 3,272
|
398
-0.5%
|
8.22
|
USD 3,272
|
|
|
2023-12-20 |
2023-12-18 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
290
-0.6%
8.22
USD 2,384
|
290
-0.6%
|
8.22
|
USD 2,384
|
|
|
2023-12-13 |
2023-12-12 |
S
Sale
|
Michaelson Jennifer
Chief Scientific Officer
Officer
|
1,068
-1.2%
7.81
USD 8,341
|
1,068
-1.2%
|
7.81
|
USD 8,341
|
|
|
2023-12-13 |
2023-12-12 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
1,926
-2.2%
7.81
USD 15,042
|
1,926
-2.2%
|
7.81
|
USD 15,042
|
|
|
2023-06-29 |
2023-06-28 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
759
-0.7%
11.40
USD 8,653
|
759
-0.7%
|
11.40
|
USD 8,653
|
|
|
2023-06-21 |
2023-06-20 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
399
-0.5%
12.94
USD 5,163
|
399
-0.5%
|
12.94
|
USD 5,163
|
|
|
2023-06-21 |
2023-06-20 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
291
-0.6%
12.94
USD 3,766
|
291
-0.6%
|
12.94
|
USD 3,766
|
|
|
2023-06-21 |
2023-06-20 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
387
-0.7%
12.94
USD 5,008
|
387
-0.7%
|
12.94
|
USD 5,008
|
|
|
2023-06-21 |
2023-06-20 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
238
-0.3%
12.94
USD 3,080
|
238
-0.3%
|
12.94
|
USD 3,080
|
|
|
2023-06-14 |
2023-06-12 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
176
-0.2%
13.11
USD 2,307
|
176
-0.2%
|
13.11
|
USD 2,307
|
|
|
2023-06-14 |
2023-06-12 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
319
-0.4%
13.11
USD 4,182
|
319
-0.4%
|
13.11
|
USD 4,182
|
|
|
2023-06-08 |
2023-06-07 |
PS
Planned sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
100
-0.1%
12.40
USD 1,240
|
100
-0.1%
|
12.40
|
USD 1,240
|
|
|
2023-06-08 |
2023-06-06 |
PS
Planned sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
11,900
-11.6%
12.31
USD 146,489
|
11,900
-11.6%
|
12.31
|
USD 146,489
|
|
|
2023-05-24 |
2023-05-23 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
707
-0.6%
9.15
USD 6,469
|
707
-0.6%
|
9.15
|
USD 6,469
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
239
-0.3%
8.76
USD 2,094
|
239
-0.3%
|
8.76
|
USD 2,094
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
291
-0.6%
8.76
USD 2,549
|
291
-0.6%
|
8.76
|
USD 2,549
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
394
-0.7%
8.76
USD 3,451
|
394
-0.7%
|
8.76
|
USD 3,451
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
399
-0.5%
8.76
USD 3,495
|
399
-0.5%
|
8.76
|
USD 3,495
|
|
|
2023-05-16 |
2023-05-12 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
347
-0.4%
8.78
USD 3,047
|
347
-0.4%
|
8.78
|
USD 3,047
|
|
|
2023-05-16 |
2023-05-12 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
193
-0.2%
8.78
USD 1,695
|
193
-0.2%
|
8.78
|
USD 1,695
|
|
|
2023-04-26 |
2023-04-25 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
716
-0.6%
10.59
USD 7,582
|
716
-0.6%
|
10.59
|
USD 7,582
|
|
|
2023-04-20 |
2023-04-18 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
238
-0.3%
10.71
USD 2,549
|
238
-0.3%
|
10.71
|
USD 2,549
|
|
|
2023-04-20 |
2023-04-18 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
392
-0.7%
10.71
USD 4,198
|
392
-0.7%
|
10.71
|
USD 4,198
|
|
|
2023-04-20 |
2023-04-18 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
398
-0.5%
10.71
USD 4,263
|
398
-0.5%
|
10.71
|
USD 4,263
|
|
|
2023-04-20 |
2023-04-18 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
290
-0.6%
10.71
USD 3,106
|
290
-0.6%
|
10.71
|
USD 3,106
|
|
|
2023-04-14 |
2023-04-12 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
176
-0.2%
10.22
USD 1,799
|
176
-0.2%
|
10.22
|
USD 1,799
|
|
|
2023-04-14 |
2023-04-12 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
318
-0.4%
10.22
USD 3,250
|
318
-0.4%
|
10.22
|
USD 3,250
|
|
|
2023-03-27 |
2023-03-23 |
S
Sale
|
AHMED NADIM
President and CEO
Executive Director
|
706
-0.6%
10.51
USD 7,420
|
706
-0.6%
|
10.51
|
USD 7,420
|
|
|
2023-03-27 |
2023-03-20 |
S
Sale
|
SUMER JACQUELYN L
Chief Legal Officer
Officer
|
305
-0.6%
11.32
USD 3,453
|
305
-0.6%
|
11.32
|
USD 3,453
|
|
|
2023-03-27 |
2023-03-20 |
S
Sale
|
Trigilio Jeffrey
Chief Financial Officer
Officer
|
399
-0.5%
11.32
USD 4,517
|
399
-0.5%
|
11.32
|
USD 4,517
|
|
|
2023-03-27 |
2023-03-20 |
S
Sale
|
Jones Jeffrey Alan
Chief Medical Officer
Officer
|
390
-0.7%
11.32
USD 4,415
|
390
-0.7%
|
11.32
|
USD 4,415
|
|
|
2023-03-27 |
2023-03-20 |
S
Sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
238
-0.3%
11.32
USD 2,694
|
238
-0.3%
|
11.32
|
USD 2,694
|
|
|
2022-11-29 |
2022-11-25 |
PS
Planned sale
|
Michaelson Jennifer
See Remarks
Officer
|
4,000
-7.0%
13.30
USD 53,200
|
4,000
-7.0%
|
13.30
|
USD 53,200
|
|
|
2022-09-29 |
2022-09-27 |
PS
Planned sale
|
Michaelson Jennifer
See Remarks
Officer
|
4,000
-7.0%
12.40
USD 49,600
|
4,000
-7.0%
|
12.40
|
USD 49,600
|
|
|
2022-08-09 |
2022-08-08 |
PS
Planned sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
1,385
-2.5%
15.01
USD 20,789
|
1,385
-2.5%
|
15.01
|
USD 20,789
|
|
|
2022-08-04 |
2022-08-04 |
S
Sale
|
F2 Vision SCS
Large shareholder
|
25,989
-2.0%
14.31
USD 371,788
|
25,989
-2.0%
|
14.31
|
USD 371,788
|
|
|
2022-08-04 |
2022-08-03 |
S
Sale
|
F2 Vision SCS
Large shareholder
|
19,129
-1.5%
14.24
USD 272,334
|
19,129
-1.5%
|
14.24
|
USD 272,334
|
|
|
2022-08-04 |
2022-08-02 |
S
Sale
|
F2 Vision SCS
Large shareholder
|
4,792
-0.4%
14.10
USD 67,554
|
4,792
-0.4%
|
14.10
|
USD 67,554
|
|
|
2022-07-26 |
2022-07-25 |
PS
Planned sale
|
Michaelson Jennifer
Chief Development Officer
Officer
|
8,000
-13.1%
14.51
USD 116,080
|
8,000
-13.1%
|
14.51
|
USD 116,080
|
|
|
2022-07-21 |
2022-07-19 |
PS
Planned sale
|
Savill Corrine
Acting Chief Business Officer
Officer
|
14,958
-9.1%
15.22
USD 227,661
|
14,958
-9.1%
|
15.22
|
USD 227,661
|
|
|
2022-07-21 |
2022-07-18 |
PS
Planned sale
|
Savill Corrine
Acting Chief Business Officer
Officer
|
5,042
-3.0%
15.06
USD 75,933
|
5,042
-3.0%
|
15.06
|
USD 75,933
|
|
|
2022-07-12 |
2022-07-11 |
PS
Planned sale
|
Savill Corrine
Acting Chief Business Officer
Officer
|
200
-0.1%
13.85
USD 2,770
|
200
-0.1%
|
13.85
|
USD 2,770
|
|
|
2022-07-12 |
2022-07-11 |
PS
Planned sale
|
Savill Corrine
Acting Chief Business Officer
Officer
|
39,800
-19.0%
13.33
USD 530,534
|
39,800
-19.0%
|
13.33
|
USD 530,534
|
|
|
2022-06-23 |
2022-06-23 |
S
Sale
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
29,631
-5.2%
13.00
USD 385,310
|
29,631
-5.2%
|
13.00
|
USD 385,310
|
|
|
2022-06-23 |
2022-06-22 |
S
Sale
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
49,953
-8.1%
12.70
USD 634,578
|
49,953
-8.1%
|
12.70
|
USD 634,578
|
|
|
2022-06-23 |
2022-06-21 |
S
Sale
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
22,319
-3.5%
12.77
USD 284,929
|
22,319
-3.5%
|
12.77
|
USD 284,929
|
|
|
2022-06-07 |
2022-06-06 |
B
Purchase
|
AHMED NADIM
President and CEO
Executive Director
|
8,090
+inf%
12.40
USD 100,316
|
8,090
+inf%
|
12.40
|
USD 100,316
|
|
